Work

Safety and feasibility of intramuscular pNGVL4a-CRTE6E7L2 and TA-CIN administration for the treatment of patients with HPV16+ atypical squamous cells of unknown significance or low-grade squamous intraepithelial lesion: A phase I clinical trial

Year: 2025

Type: article

Study design: Clinical Trial

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2025.04.065

Authors: Kimberly Levinson, Rebecca Arend, Richard Roden, Tullia Rushton, Peter Ketch, Dana Lewis, Darin Ostrander, Ashish Solanki, Alexis Peay, Hao Wang, Sejong Bae, Sellers Swann, Christopher Mayer, Emily O'Brien, Fibiana Oladipo, Charles Leath, T.-C. Wu, Warner Huh

Institutions: Johns Hopkins University, University of Alabama at Birmingham, Johns Hopkins Medicine

Language: English

Topic: Cervical Cancer and HPV Research

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4414649836

FWCI:

Cites:

Cited by:

Related to: 10